Maria Rohm
Neuherberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Reframing cancer cachexia: from malnutrition to treatable disease.
Journal: Nature reviews. Endocrinology
Published: July 14, 2026
Pre-clinical cancer cachexia causes glucose hypermetabolism prior to overt weight loss.
Journal: Molecular metabolism
Published: March 16, 2026
Hepatokines lipocalin 2 and osteopontin drive muscle atrophy in MASH.
Journal: Molecular metabolism
Published: March 12, 2026
Hepatokines lipocalin 2 and osteopontin drive muscle atrophy in MASH.
Journal: Molecular metabolism
Published: March 12, 2026
Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia.
Journal: Cancer discovery
Published: January 09, 2026
Nuclear receptor co-factor TBL1X/TBL1XR1 T cell activity protects against atherosclerosis.
Journal: Molecular metabolism
Published: December 12, 2025
Reawakening cAMP signalling in cancer cachexia.
Journal: Nature metabolism
Published: November 12, 2025
Muscle-immune metabolic crosstalk: shared pathways in cachexia and exercise.
Journal: Current opinion in biotechnology
Published: October 22, 2025
Acsbg1 maintains intestinal immune homeostasis and controls inflammation by regulating ST2+ Tregs.
Journal: Mucosal immunology
Published: April 29, 2025
Inhibition of ceramide synthesis ameliorates body wasting in a cancer cachexia model.
Journal: The Journal of clinical investigation
Published: April 17, 2025
Lipidated interleukin-22 reduces body weight and spares lean mass in mice by a novel gut-acting mechanism additive to GLP-1 agonism.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 04, 2025
Last Updated: 09/26/2026